【麦肯锡】what-can-we-expect-in-china-in-2019.pdf

Apple FY1Q23 miss on macro and supply chain issues; Expect weakness to persist in near term

China Pharmaceutical & Healthcare: Expecting global funding recovery in the coming quarters

We expect 1H24 to be still profitable

2Q loss reduction trend better than expectation

Expect domestic business to rebound from 2025

Turnaround is here but weaker than expected

Natural gas HDT +14.8x YoY in Oct on low base; Expect momentum to continue; Weichai our top pick

China Economy – Exports continued to beat expectations with uncertainty ahead

China Property Sector：NBS Sep data： gloomy as expected, no strong rebound, only mild recovery in 4Q in our view

what-can-we-expect-in-china-in-2017